Publication:
Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy (2012)
Author(s): Danielli R, Ridolfi R, Chiarion-Sileni V, Queirolo P, Testori A, Plummer R, Boitano M, Calabro L, De Rossi C, Di Giacomo AM, Ferrucci PF, Ridolfi L, Altomonte M, Miracco C, Balestrazzi A, Maio M
- Date: 11-08-2011
- Journal: Cancer Immunology, Immunotherapy
- Volume: 61
- Issue: 1
- Pages: 41-48
- Publisher: Springer
- Publication type: Article
- Bibliographic status: Published
- URL: http://dx.doi.org/10.1007/s00262-011-1089-0
- DOI: 10.1007/s00262-011-1089-0
- ISSN (electronic): 1432-0851
Keywords: Uveal melanoma Ipilimumab Cytotoxic T-lymphocyte antigen-4 Melanoma Immunotherapy T-LYMPHOCYTE ANTIGEN-4 CHOROIDAL MELANOMA PHASE-II ANTI-CTLA-4 ANTIBODY PROGNOSTIC-FACTORS LIVER METASTASES SURVIVAL EXPERIENCE ENUCLEATION MORTALITY
|
Professor Ruth Plummer
|
|
